Kathmere Capital Management, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,178 filers reported holding NOVARTIS A G in Q2 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
Kathmere Capital Management, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$1,146,027
+10.6%
11,251
+9.6%
0.17%
+5.6%
Q2 2023$1,035,841
+18.4%
10,265
+7.9%
0.16%
+12.6%
Q1 2023$874,920
-53.0%
9,510
-53.3%
0.14%
-10.1%
Q4 2022$1,862,598
+426.2%
20,349
+386.6%
0.16%
+144.6%
Q2 2022$354,000
+24.2%
4,182
+28.9%
0.06%
+35.4%
Q1 2022$285,0003,2440.05%
Other shareholders
NOVARTIS A G shareholders Q2 2023
NameSharesValueWeighting ↓
MANAGED ASSET PORTFOLIOS, LLC 332,962$27,452,0007.32%
Mawer Investment Management Ltd. 7,721,327$636,623,0005.86%
Martin Investment Management, LLC 133,246$10,986,0005.56%
SCHARF INVESTMENTS, LLC 1,330,175$109,673,0005.48%
Hansberger Growth Investors, LP 46,663$3,847,0005.19%
Bain Capital Public Equity Management II, LLC 440,233$36,297,0004.25%
First Fiduciary Investment Counsel, Inc. 187,633$15,470,0004.10%
GARLAND CAPITAL MANAGEMENT INC 53,555$4,416,0004.02%
Lowell Blake & Associates Inc. 37,219$3,069,0003.94%
PRENTISS SMITH & CO INC 68,027$5,609,0003.89%
View complete list of NOVARTIS A G shareholders